Razelle Kurzrock: Is it time to move from tissue-based to molecular cancer classification?
Razelle Kurzrock shared post on X:
”Our Precision Leaders summit panel.
Is it time to move from tissue-based to molecular cancer classification? (Y’all know my answer).”
Dr. Razelle Kurzrock is the Associate Director of Clinical Research and Precision Oncology at the Medical College of Wisconsin. She is also the Chief Medical Officer at WIN Consortium, Senior Deputy Director at the HKSH Cancer Centre, and Senior Advisor at CureScience. She is also a Professor of Medicine at the University of California, San Diego (UCSD) and the Director of the Center for Personalized Cancer Therapy at UCSD. Additionally, Dr. Kurzrock is the founding director of the Michels Rare Cancers Research Laboratories at the MCW Cancer Center. Renowned as one of the world’s top 25 voices in precision medicine, she is celebrated for her contributions, of having over 950 scientific and medical publications.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023